| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2003;41:1219.)
© 2003 American Heart Association, Inc.
Scientific Contributions |
From the Department of Kinesiology and Applied Physiology, University of Colorado (D.D.C., P.P.J., D.R.S.), Boulder, Colo; and the Department of Medicine, University of Colorado Health Sciences Center (D.R.S.), Denver, Colo.
Correspondence to Demetra Christou, PhD, Department of Kinesiology and Applied Physiology, University of Colorado at Boulder, UCB 354, Boulder, CO, 80309. E-mail christou{at}colorado.edu
| Abstract |
|---|
|
|
|---|
Key Words: arterial pressure autonomic nervous system baroreflex exercise phenylephrine
| Introduction |
|---|
|
|
|---|
Regular aerobic-endurance exercise is widely recommended as a lifestyle behavior for reducing the risk of cardiovascular and other chronic diseases.6,7 However, despite extensive investigation in both humans and experimental animals, the influence of habitual aerobic-endurance exercise on baroreflex function remains controversial. Efforts to date have focused either on certain characteristics of the reflex function or on measuring the sensitivity (responsiveness) of baroreflexes. The results of these studies are equivocal, with baroreceptor function variously reported as being augmented,813 not different12,1419 or reduced,14,2024 in healthy exercise-trained compared with untrained subjects.
Recently, Jordan and colleagues3,4 presented a novel experimental approach for determining baroreflex buffering in humans, which we have established in our laboratory.3 In this model, neurotransmission in the autonomic ganglia is interrupted pharmacologically with the use of trimethaphan, thus abolishing baroreflex modulation of cardiac output and vascular resistance in response to changes in BP evoked by an adrenergic receptor agonist. The magnitude of the increase in the BP response to phenylephrine during compared with before ganglionic blockade provides a measure of the in vivo buffering capacity of the baroreflexes. This approach may better characterize the in vivo physiological function of the baroreflexes rather than simply assessing heart period or sympathetic neural responsiveness to BP perturbations as in standard baroreflex testing. In the current study, we used this new method to determine if baroreflex buffering capacity differs in the aerobic-endurance exercisetrained compared with the untrained physiological states in healthy adult humans.
| Methods |
|---|
|
|
|---|
4 days per week, continuously for the last 2 years, and were top finishers in local racing events. The untrained men had not performed any regular exercise for at least 2 years. All procedures were approved by the Colorado Multiple Institutional Review Board and the Human Research Committee, and written informed consent was obtained from all subjects.
Experimental Procedures
All procedures were performed in the University of Colorado General Clinical Research Center or in the Human Cardiovascular Research Laboratory as described in detail previously.3 Maximal oxygen consumption was measured by on-line computer-assisted open circuit spirometry during incremental treadmill exercise as described in detail previously.25 On a separate day, starting early in the morning after an overnight fast, subjects were studied during supine rest. BP was measured directly through a radial artery catheter. Baseline BP variability was determined over a 5-minute period before ganglionic blockade by using the standard deviation of the beat-to-beat systolic and diastolic peaks of the BP wave forms. Heart rate variability (HRV) was determined as described previously2,26 and was used as a measure of tonic cardiac vagal modulation of heart rate. On a separate morning under fasting conditions, multiunit recordings of muscle sympathetic nerve activity (MSNA) were obtained from the right peroneal nerve at the fibular head by use of the microneurographic technique, as described previously.2,27
The protocol has recently been described in detail.3,4 BP responses to intravenous administration of (a) a standard bolus dose of phenylephrine (25 µg) and (b) 6-minute steady-state incremental infusions of phenylephrine (0.02, 0.04, 0.08, and 0.16 µg/kg per minute) were determined before and during ganglionic blockade (intravenous trimethaphan). The latter was established by absence of a change in heart rate in response to bolus injection of phenylephrine (25, 50, and/or 100 µg).
Baroreflex buffering4 was measured (a) as the potentiation of the systolic and mean arterial BP responses to a standard 25-µg bolus dose of phenylephrine (BRBbolus) during compared with before ganglionic blockade and (b) as the change in the slope of the increase in systolic and mean BP in response to the incremental infusion of phenylephrine (BRBslope) from baseline to ganglionic blockade, as described recently.3
Statistical Analyses
Differences between endurance exercisetrained and untrained subjects for baseline characteristics and baroreflex buffering were made with the use of t tests for independent group comparisons. BP responses to phenylephrine before and during ganglionic blockade were analyzed by means of a 2-way ANOVA with repeated measures [groupxcondition (baseline versus ganglionic blockade)]. Statistical significance was based on differences of P<0.05 or greater. All data are reported as mean±SEM.
| Results |
|---|
|
|
|---|
|
The increases in systolic BP in response to phenylephrine were not different in the exercise-trained and untrained men before or during ganglionic blockade (left panels, Figures 1 and 2
). BRBbolus (3.9±0.8 versus 4.0±0.7, trained versus untrained, P=0.9) and BRBslope (2.8±0.4 versus 2.5±0.6, P=0.67) were similar in the 2 groups (right panels, Figures 1 and 2
). BRB values also were similar in the 2 groups when the mean BP responses to phenylephrine were used.
|
|
| Discussion |
|---|
|
|
|---|
Conventional assessments of baroreflex function are helpful for determining how (a) selective characteristics of the baroreflex (eg, gain; response range; saturation) or (b) heart rate and sympathetic neural responsiveness to baroreflex perturbations may differ between subject populations or physiological states. However, these experimental approaches do not provide direct insight into the effectiveness of the actual BP-buffering capacity of baroreflexes under normal in vivo conditions. The results of the present investigation provide the first such insight into the possible effects of habitual exercise on this function. Our findings support the idea that aerobic-endurance exercise training does not modulate the BP buffering capacity of the baroreflexes in healthy humans.
Because BRB does not differ in healthy endurance exercisetrained and untrained adults, one might postulate that neither would the BP responses to standardized sympathetic nervous system adrenergic stimuli. Our related observations are consistent with this concept. For example, we have demonstrated previously that BP responsiveness to both physiological stimuli such as experimental hypovolemia, isometric exercise, and limb immersion in cold water28,29 and pharmacological stimulation of
-adrenergic receptors30 are similar in endurance-trained and untrained healthy men.
There are at least two limitations of the current study that should be mentioned. First, because of safety concerns for human subjects, we did not determine BRB in response to reductions in BP evoked by administration of a vasodilating drug such as sodium nitroprusside. Ganglionic blockade reduces baseline BP to very low levels in certain individuals, and the addition of a vasodilator might prove harmful under these conditions. However, Jordan and colleagues4 observed the same group differences in BP responses and baroreflex buffering by using phenylephrine and sodium nitroprusside. Second, our results are limited largely to endurance exercisetrained and untrained healthy white men. There is no evidence to suggest differences in endurance-trained compared with untrained women or healthy adults varying in ethnicity. However, the current findings should not be generalized to other types of habitual exercise (eg, resistance training) or to patients with chronic cardiovascular or metabolic diseases.
Perspectives
Regular aerobic-endurance exercise is associated with enhanced physical work capacity (fitness) as well as reduced risk of developing chronic cardiovascular and metabolic diseases. As such, for many years, moderate to vigorous habitual exercise has been recommended by a variety of organizations with interests in public health including the American Heart Association.7 However, to those of us familiar with the cardiovascular exercise physiology scientific literature, there has been a lingering concern as to whether regular aerobic-endurance exercise causes problems with BP control mediated, at least in part, by impairment of baroreflex function.21,23,31,32 Cogent arguments have been made supporting31 and refuting33 this idea. Regular exercise of the type performed by most adults for fitness and health purposes does not appear to produce obvious detrimental effects on BP control. The results of our study are consistent with this observation, suggesting that even frequent and strenuous endurance exercisetraining is not associated with an impairment in the in vivo buffering capacity of the baroreflexes in healthy humans. Thus, although some characteristics of baroreflex function may differ in the sedentary and endurance-trained states,814,20,2224,31 our findings suggest that there should be no concern that adverse effects on baroreflex-mediated BP control will occur as a result of vigorous regular aerobic exercise in healthy adults.
| Acknowledgments |
|---|
Received February 10, 2003; first decision February 24, 2003; accepted April 3, 2003.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. R. Stob, D. R. Seals, J. Jensen, M. A. van Baak, A. J. Steig, R. C. Lindstrom, B. T. Bikman, and C. Bell Autonomic Neuroscience: Increased thermogenic responsiveness to intravenous {beta}-adrenergic stimulation in habitually exercising humans is not related to skeletal muscle {beta}2-adrenergic receptor density Exp Physiol, September 1, 2007; 92(5): 823 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Stob, C. Bell, M. A. van Baak, and D. R. Seals Thermic effect of food and beta-adrenergic thermogenic responsiveness in habitually exercising and sedentary healthy adult humans J Appl Physiol, August 1, 2007; 103(2): 616 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. van de Vooren, M. G. J. Gademan, C. A. Swenne, B. J. TenVoorde, M. J. Schalij, and E. E. Van der Wall Baroreflex sensitivity, blood pressure buffering, and resonance: what are the links? Computer simulation of healthy subjects and heart failure patients J Appl Physiol, April 1, 2007; 102(4): 1348 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bell, N. R. Stob, and D. R. Seals Thermogenic responsiveness to nonspecific beta-adrenergic stimulation is not related to genetic variation in codon 16 of the beta2-adrenergic receptor Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E703 - E707. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bell, N. R. Stob, and D. R. Seals Thermogenic responsiveness to {beta}-adrenergic stimulation is augmented in exercising versus sedentary adults: role of oxidative stress J. Physiol., February 1, 2006; 570(3): 629 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Christou, P. P. Jones, J. Jordan, A. Diedrich, D. Robertson, and D. R. Seals Women Have Lower Tonic Autonomic Support of Arterial Blood Pressure and Less Effective Baroreflex Buffering Than Men Circulation, February 1, 2005; 111(4): 494 - 498. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |